高管洗牌、业绩承压,白云山药业能否重整旗鼓?

文轩财经
26 Dec 2024

图源:网络(侵删)近日,广州白云山刚辞职的副总经理黄海文被传出已被相关部门带走调查,这已经半年内白云山第三次出现高管辞职被调查。曾经风光无限的白云山正面临业绩和市值下滑的双重压力。01内讧不断 曾被相关部门通报2019年,北京康业元投资顾问有限公司发表了一篇题为《针对广药集团董事长李楚源违法违纪的实名公开信》,指控控告白云山及其董事长李楚源涉嫌违反《证券法》、《公司法》等相关规定,侵害了合作伙伴...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10